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Abstract
Previous in vitro results indicated that alginate beads might be a useful vehicle for food iron fortification. A human study
was undertaken to test the hypothesis that alginate enhances iron absorption. A randomised, single blinded, cross-over trial
was carried out in which iron absorption was measured from serum iron appearance after a test meal. Overnight-fasted
volunteers (n = 15) were given a test meal of 200 g cola-flavoured jelly plus 21 mg iron as ferrous gluconate, either in
alginate beads mixed into the jelly or in a capsule. Iron absorption was lower from the alginate beads than from ferrous
gluconate (8.5% and 12.6% respectively, p = 0.003). Sub-group B (n = 9) consumed the test meals together with 600 mg
calcium to determine whether alginate modified the inhibitory effect of calcium. Calcium reduced iron absorption from
ferrous gluconate by 51%, from 11.5% to 5.6% (p= 0.014), and from alginate beads by 37%, from 8.3% to 5.2% (p= 0.009). In
vitro studies using Caco-2 cells were designed to explore the reasons for the difference between the previous in vitro
findings and the human study; confirmed the inhibitory effect of alginate. Beads similar to those used in the human study
were subjected to simulated gastrointestinal digestion, with and without cola jelly, and the digestate applied to Caco-2
cells. Both alginate and cola jelly significantly reduced iron uptake into the cells, by 34% (p= 0.009) and 35% (p = 0.003)
respectively. The combination of cola jelly and calcium produced a very low ferritin response, 16.5% (p,0.001) of that
observed with ferrous gluconate alone. The results of these studies demonstrate that alginate beads are not a useful
delivery system for soluble salts of iron for the purpose of food fortification.
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Introduction
Iron fortification is a widely used strategy to reduce the risk of
iron deficiency but it presents a major challenge to the food
industry. Water soluble forms of iron, such as ferrous gluconate
[1], are generally more bioavailable than non-soluble iron
compounds, but they can cause adverse organoleptic changes
when added to foods [2]. Iron chelators such as ascorbic acid,
sodium ethylenediaminetetraacetic acid (EDTA) and nicotiana-
mine increase iron bioavailability by preventing the formation of
insoluble ferric hydroxide and protecting the iron from binding
with substances such as phytate which render the iron unavailable
for absorption [3,4,5]. However, the complexes may be unstable
during food processing and storage, and/or cause discoloration of
the food products [5,6]. Alginates bind divalent metals and could
provide an alternative delivery system to maximise iron absorption
in iron fortification programmes.
Alginates are natural copolymers present in the cell walls of
brown seaweed as sodium, potassium, calcium and magnesium
salts of alginic acid. They are comprised of varying ratios of two
different acids: D-mannuronic and L-guluronic acid, and due to
the variable length of the polymer chains they exhibit differing
physiochemical properties [7]. Alginates are widely used in variety
of applications, including the food industry (as thickening, gelling,
emulsifying and stabilising agents in food products (ice cream,
sauces, fruit pies) [8] and drug delivery systems (anti-reflux
preparations) [9]. They have been shown to bind divalent and
trivalent cations and form a stable complex with iron (III) over a
range of different pH values [10,11], and therefore may provide a
useful vehicle for soluble iron compounds used to fortify foods.
Previous in vitro studies demonstrated that alginate solutions
had an enhancing effect on iron uptake (measured by ferritin
formation) in a Caco-2 cell model system, and alginate beads
containing ferrous gluconate delivered more available iron than
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beads containing ferric ammonium citrate [12]. In contrast,
studies in ileostomy patients suggested a potential inhibitory effect
of alginate on iron absorption; but as the study was underpowered
no clear conclusions could be drawn [13].
The aim of this work was to examine the effect of alginate on
iron absorption in order to determine whether it could be a useful
mechanism for fortifying selected foods with iron. Iron absorption
from alginate beads saturated with ferrous gluconate and ferrous
gluconate on its own were compared in a group of human
volunteers. In addition, the effect of calcium on iron absorption
was investigated. Calcium is required for alginate bead production
but is a known inhibitor of iron absorption in single meal studies
[14]. The first hypothesis tested was that alginate in iron-
containing alginate beads conferred protection to the iron in the
gastrointestinal tract and delivered more available iron for
absorption into the mucosal cells of the duodenum than ferrous
gluconate administered in a gelatine capsule. The second
hypothesis tested was that calcium in the gut lumen would bind
to alginate thereby reducing its inhibitory effect on iron
absorption. Following on from the human study, in vitro
experiments were performed to identify possible explanations for
the in vivo findings.
Materials and Methods
Human study
Volunteers were selected from populations with a higher
prevalence of low iron stores, namely women of child-bearing
age (18–45 years old) and men who were regular blood donors
(aged 18–65 years old). Iron absorption is up-regulated when
ferritin values are low to moderate (ferritin ,60 mg/L) [14], thus
selecting individuals with a ferritin ,60 mg/L increases the
sensitivity of the absorption test. Volunteers were recruited locally
from advertisements, websites and email. Recruitment started on
12th March 2012 and finished on 3rd August 2012. All
appointments (initial interview, screening visit and study days)
were carried out by the study scientist and took place in the
Clinical Research Facility at the University of East Anglia
Norwich Medical School (Figure 1). The study participants were
young females aged 19–27 y, with the exception of one male, aged
49 y. Subject characteristics are presented in Table 1 and
individual data in Table S1. Each person underwent a basic
health check (hematological analysis and a simple health
questionnaire) and blood pressure, weight and height were
recorded. Underweight and obese individuals (Body Mass Index
(BMI) ,18.5.30 kg/m2) were excluded. A 10 ml venous blood
sample was taken for hematological measurements and anyone
with abnormal values or a ferritin concentration ,15 or .60 mg/
L was excluded.
The study was a randomised, single blinded, cross-over trial
(Figure 2). The protocol for this trial and supporting CONSORT
checklist are available as supporting information, see Protocol S1
and Checklist S1. Test materials were given after an overnight fast
and iron appearance in the serum was measured over 6 h
[15,16,17] employing a method that has been previously validated
for quantifying iron absorption [18]. Participants acted as their
own controls and were randomly allocated into two groups, Group
A (n = 15 volunteers) and sub-group B (n= 9 volunteers).
Randomization was undertaken by a third party unconnected
with the study using a randomization generator (www.
randomization.com). Randomisation was generated for 16 se-
quential volunteers, and each random sequence generated was
placed in order in a sequentially numbered (1–16), opaque, sealed
envelope. As each volunteer was recruited onto the study, the
appropriately numbered envelope was opened by the study
scientist to reveal the assignment to group A or B. A total of 34
subjects were assessed for eligibility, 14 were excluded due to not
meeting inclusion criteria, 1 volunteer declined to participate. 19
volunteers were randomized to the treatments out of which 2 were
withdrawn due to the medical reasons and 1 withdrew due to the
relocation. One participant was lost to follow up due to relocation.
A total of 15 volunteers completed the study which started on 24th
April 2012 and finished on 6th September 2012.
The data were subjected to compartmental modelling to
calculate percentage iron absorption [18]. Group A participated
in 2 out of the 4 tests, whereas sub-group B participated in all 4
tests. Each test was separated by a minimum 7 d wash-out period
(Figure 2). The tests were statistically powered to ensure that the
minimum number of study participants was involved in order to
address the research question.
The preparation of iron-containing alginate beads took
approximately 32 h, and was timed such that the beads were
ready for consumption by the participants on the morning of the
study day as they could only be stored for a short time in order to
be safe for human consumption. Four alginates differing in
mannuronic to guluronic acid ratio were previously investigated
for their cross-linking capacity of ferrous gluconate in the presence
of calcium chloride. Results supported the hypothesis of compet-
itive binding between iron and calcium in alginate gel beads
[19,20]. Iron incorporation into the alginate beads was variable
(1.03 mg iron/g wet bead 6SD 0.11), therefore sub-samples of
every batch of beads were analysed for iron by atomic absorption
spectroscopy. It was not possible to randomise the sequence of test
meal administration because for every individual the dose of iron
in the ferrous gluconate capsules had to be identical to the dose in
the alginate beads.
The beads were prepared at the Institute of Food Research,
Norwich, UK by dissolving alginate powder (Flavicans HV;
315KDalton, with D-mannuronic to L-guluronic acid ratio of 35/
65 and viscosity 1% 350 cp; Danisco, DK) in distilled water. The
alginate solution (0.5% (w/v (weight per volume)) was subsequent-
ly passed through an encapsulator (‘Startup’; EncapBioSystems
Inc, Switzerland) where the solution was broken into equally sized
beads by vibrations. The alginate droplets were then collected into
a solution containing ferrous gluconate (0.1 M) and calcium
chloride (0.1 M) and left to soak for 20 h at 4uC in order to
crosslink and saturate with iron. Beads were then filtered for 5 min
through Whatman (grade 4) filter paper and rinsed with distilled
water.
Cola flavoured jelly (to mask the metallic taste of iron) was
selected as a test meal, based on research conducted by Collings
et al [21] that established that a cola drink did not affect iron
absorption. Cola-flavoured jelly, into which the beads were mixed
for consumption by the volunteers, was prepared by heating
200 ml of Coca-Cola in a microwave, adding 10 ml of Diet Cola
flavoured drink concentrate (Sodastream, Lakeland) and 5 g of
gelatine (Dr. Oetker, UK) and mixing until the gelatine was fully
dissolved. Once cooled, 200 ml of the liquid jelly was poured into
a disposable plastic cup and allowed to set in a refrigerator at 4uC.
Test meals were comprised of 200 g cola jelly and 200 ml of
Diet Cola drink. Test meal 1 (iron in alginate beads) contained
approximately 21 mg of iron as ferrous gluconate, (a quantity
sufficient to perturb normal serum iron concentrations [16]), as
iron-saturated alginate beads and 3 gelatine capsules (Distinctive
Medical, UK) that contained approximately 50 mg dextrose each
(acting as placebo). Test meal 1 (iron-containing alginate beads)
also contained a calcium:iron ratio of 2.7:1.0 as calcium was
needed in the production of the beads. Test meal 2 (iron in the
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Figure 1. Flow diagram of human study. Number of participants at every stage (CONSORT statement).
doi:10.1371/journal.pone.0112144.g001
Table 1. Characteristics of volunteers.1
Test meal 1 (Beads +Fe) Test meal 2 (Fe)
Test meal 3
(Beads + Fe+ Ca) Test meal 4 (Fe + Ca)
Group A Sub-group B Group A Sub-group B Sub-group B Sub-group B
Age (y) 24.267.9 27.5612.4 – – – –
BMI (kg/m2) 22.061.9 21.762.2 – – – –
CRP (mg/L) 1.861.4 1.460.5 1.561.1 1.260.4 1.660.9 1.861.1
Ferritin (mg/L) 26.269.9 26.4610.5 20.069.4 18.568.4 24.3619.0 18.4612.9
sTfR (mg/L) 6.063.0 6.363.1 6.362.9 6.362.3 7.062.6 6.662.1
BI (mg/kg) 3.9 62.2 3.862.6 2.562.3 2.362.1 2.3 63.5 1.563.6
1Values are means 6 SD.
BMI, Body Mass Index; CRP, C-reactive protein; sTfR, soluble transferrin receptor; BI, body iron.
doi:10.1371/journal.pone.0112144.t001
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capsule) contained approximately 21 mg of iron (ferrous gluco-
nate) in a gelatine capsule and 2 placebo capsules (each containing
50 mg of dextrose), and no added calcium. A sub-set of volunteers
(Group B) underwent two further tests: test meal 3 (iron in alginate
beads plus 600 mg calcium) with iron containing alginate beads, 2
capsules with 300 mg of calcium phosphate each and 1 placebo
capsule (calcium:iron ratio 13.6:1.0) and test meal 4 (iron in the
capsule plus 600 mg calcium) with iron in the capsule and 2
capsules with 300 mg of calcium phosphate each (calcium:iron
ratio 11.0:1.0). All participants and clinical staff were blinded to
the treatments.
On the day before the first test meal participants recorded all
food and drinks in a food diary and consumed exactly the same
diet every pre-test day. They began an overnight fast from 22:00 h
and attended the UEA Clinical Trials Unit at 08.00 h. An
intravenous cannula was inserted into a peripheral vein and a 5 ml
baseline blood sample was taken. The test meal was consumed and
5 ml blood samples were taken at 20, 40, 60, 80, 100, 120, 150,
180, 240, 300 and 360 min. The cannula was flushed with sterile
normal saline between blood samples to maintain its patency.
During the 6 h cannulation period volunteers had free access to
drinking water. There were no adverse events or serious adverse
events reported.
All blood samples were measured for total serum iron; baseline
blood samples were also analysed for serum ferritin and soluble
transferrin receptor. Following blood collection into trace element-
and EDTA-free tubes (BD Vacutainer, UK) the samples were
allowed to stand at room temperature for a period of 30–45 min
and then centrifuged at 500 g. The serum was removed and stored
in microtubes (Sarstedt, Leicester, UK) at 280uC. Total serum
iron was measured in duplicate using the Quantichrom (BioAssay
Systems, USA) iron assay kit. Serum ferritin was analysed using a
ferritin enzyme immunoassay kit (Ramco, Stafford, Texas, USA),
with a mean CV of 10% (duplicate measurements). Serum soluble
transferrin receptor (sTfR) was analysed using TfR enzyme
immunoassay kit (Ramco, Stafford, Texas, USA), with a mean
CV of 4% (duplicate measurements). In order to ensure
comparability between the TfR enzyme immunoassay kit used
in this study and those used in other publications the World Health
Organization’s (WHO) reference reagent (recombinant soluble
transferrin receptor (rsTfR) National Institute for Biological
Standards and Control, Potters Bar, Hertfordshire, UK) at two
Figure 2. Study protocol and time-lines.
doi:10.1371/journal.pone.0112144.g002
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different concentrations, was measured on each sTfR plate with a
mean value (n = 11) of 306.7 (6SD 45.5) mol/L.
C-reactive protein (CRP) concentration was measured in order
to establish whether there was any low grade inflammation or
infection which would affect iron metabolism. CRP measurements
were performed at an accredited pathology laboratory at the
Pathology Department of the Norfolk and Norwich University
Hospital, Norwich, UK, and samples from any individuals with
values.6 mg/L were excluded from the analysis.
As hemolysis could interfere with the Quantichrom iron assay,
the optical densities of all serum samples were compared with
standard serum (TCS Biosciences, Buckingham, UK) at hemo-
globin peak wavelengths of 415, 417, 540, 570, and 575 nm.
Hemolysis was detected in 9.5% of the samples, and these were
excluded from the analysis.
Percentage iron absorption of the dose administered was
calculated as follows:
Given a time of 3–6 h post-administration of the oral dose
(doseoral) the rate of infusion R was calculated from the serum iron
concentration
R~
mass of dose that is absorbed
time period for absorption
~
M
T
ð1Þ
Given a volume of distribution V, and a rate constant of
elimination from the compartment k, the concentration in the
compartment was approximated to:
C~
M
V :T :k
: 1{e{kt
 
0vtvTð Þ ð2Þ
C~
M
V :T :k
: 1{e{kT
 
:e{k(t{T) twTð Þ ð3Þ
By fitting the equations to the concentration data, M, T and k
were calculated.
The fractional absorption from the oral dose was then:
Fractional absorption~
M
dose oral
ð4Þ
Ethics Statement
The human study was approved by the University of East
Anglia Faculty of Medicine and Health Research Ethics Com-
mittee on 31st November 2011 and was conducted according to
the principles expressed in the Declaration of Helsinki. Written
informed consent was obtained from every participant. The study
was registered at www.clinicaltrials.gov as NCT01528644.
Caco-2 Cell Studies
We reported previously that both alginate solutions and iron-
containing beads enhance iron bioavailability in vitro using the
Caco-2 cell model [12]. Following the human study, further in
vitro experiments were undertaken to examine reasons for the
discrepancy between the results of the human study and the
previous in vitro results [12]. In particular, we thought it
important to repeat the Caco-2 cell studies using beads prepared
in exactly the same way as those used in the human study, namely
washing them after preparation to remove iron adhering to the
outside of the beads, mixing into cola jelly and, where appropriate,
adding calcium to achieve the same calcium: iron molar ratio. It
was not, however, possible to replicate the iron content of the
beads exactly due to variations in iron accumulation when the
beads were soaked in the iron and calcium bath.
Caco-2 cells (HTB-37) were obtained from American Type
Culture Collection (Manassas, VA, USA) at passage 18 and
cultured in Dulbecco’s modified Eagle’s media (DMEM, ATCC,
USA); supplemented with 10% fetal bovine serum (ATCC, USA),
4 mM L-glutamine, 5 ml 5000 U/ml penicillin-streptomycillin
solution (both from Gibco, Paisley, UK) and 5 ml non-essential
amino acids 100X (Sigma, Gillingham, Dorset, UK) maintained at
37uC in an incubator with humidified atmosphere consisting of
5% carbon dioxide and 95% air. The cells were seeded onto
collagen-coated 6 well plates (Greiner, Stonehouse, UK) at a
density of 4.756104, and suspended in 2 ml of supplemented
DMEM, which was replaced every 2 days. Cells between passages
29–34 were used for experiments at 13 d post seeding. 24 h prior
to experimentation cells were switched to serum-free medium. The
average Caco-2 cell protein was 0.18 mg6SD 0.032 per cm2. The
average ferritin concentration in cells not exposed to any iron
treatment (only to digests) was 3.8 ng/mg total protein 6SD 0.7.
Alginate beads with cola jelly (and added calcium solutions in
0.1 M hydrochloric acid, where appropriate) and the positive
control (ferrous gluconate), were subjected to a simulated
gastrointestinal digestion prior to application onto a dialysis
membrane placed above the Caco-2 cell monolayer [12]. Briefly,
the samples were heated to 37uC and first underwent simulated
gastric digestion with pepsin for 1 h at pH 2, and then the pH was
gradually adjusted to 6.7 and pancreatin and bile extract were
added to simulate digestion in the upper small intestine. The digest
was applied onto the dialysis membranes placed above the Caco-2
monolayer and incubated on a rotating table for 2 h at 37uC. After
2 h the digestate was removed from the upper compartment and
the Caco-2 cells incubated for further 22 h, at which point the
media was aspirated from the 6 well plates and the cells were
washed twice with 2 ml Phosphate-Buffered Saline. Subsequently,
deionized water was applied to each well and the Caco-2 cells were
scraped off using an inverted 200 ml pipette tip. The cell
suspension from each well was transferred into 5 ml sample tubes
and sonicated on ice, 3 times for 5 sec, using a probe sonicator.
Following sonication, cell suspensions were transferred to pre-
labelled 2 ml sample tubes and stored at 220uC. Sonicated cell
lysates were defrosted and ferritin measured using a spectroferritin
ELISA assay (Ramco, Stafford, Texas, USA). Total protein was
quantified using a Pierce BCA protein assay (Fisher Scientific,
Loughborough, Leicestershire, UK). Uptake of iron by Caco-2
cells was assessed from the ferritin content (ng/mg total protein).
Statistical Methods
In order to test for an effect of alginate on iron absorption from
ferrous gluconate a minimum of 12 volunteers was required to
detect a difference of 2.5% at a significance level of 0.05 for 80%
power. In order to test whether the interaction between alginate or
ferrous gluconate and additional calcium (600 mg) affected iron
absorption, a minimum of 8 volunteers was required to detect a
difference in iron absorption of 3.3%, assuming a power of 80%, a
level of significance of 0.05 and standard deviation of differences
(within pairs) of 2.8%. Paired, two-tailed Student’s t tests were
used for Group A and Sub-group B to determine significant
differences in iron absorption. This analysis was carried out in R
version 3.0.1 [22]. For the cell studies, the statistical analysis was
performed using SPSS Inc USA (version 16.0.0); 2-factor ANOVA
Alginates and Iron Absorption
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with Tukey HSD post-hoc tests were conducted to examine
pairwise differences on power-transformed data.
Results
There were no significant differences between the subjects’
characteristics in the two groups in any of the measured variables
and no effect of time on serum ferritin and soluble transferrin
receptor concentrations (Table 1).
Iron absorption from the test meals is shown in Figure 3
(individual data in Tables S2 and S3). In several volunteers there
were too many hemolysed serum samples to calculate iron
absorption, so these data points are missing. There were complete
sets of iron absorption data for 13 individuals in Group A (2 tests)
and 6 individuals in sub-group B (all 4 tests). However, a further
volunteer from sub-group B was removed because of an elevated
CRP concentration. There were 7 complete sets (n = 7) of iron
absorption data for Test meal 1 vs 3 and for Test meal 2 vs 4.
Alginate significantly reduced mean iron absorption from 12.6%
when given as ferrous gluconate (Test meal 2) to 8.5% when given
as alginate beads (Test meal 1; p = 0.003, n= 13). As predicted,
600 mg calcium had a strongly inhibitory effect on iron
bioavailability; ferrous gluconate absorption fell from 11.5% (Test
meal 2) to 5.6% (Test meal 4; p = 0.014; n= 7). Calcium also
reduced iron absorption from the alginate beads, from 8.3%
without calcium (Test meal 1) to 5.2% with calcium (Test meal 3;
p = 0.009; n= 7).
In the previous Caco-2 cell studies alginates enhanced iron
uptake into the cells. However when alginate beads were produced
containing a lower iron concentration (with an inevitable increase
in calcium) it resulted in a lower ferritin response [12]. Additional
Caco-2 cell studies were therefore undertaken to try to find an
explanation for the difference between the in vitro and in vivo
findings.
An attempt was made to replicate the beads that were used in
the human study. When Caco-2 cells were exposed to digestate
from a simulated gastrointestinal digestion of alginate beads
containing ferrous gluconate, with and without cola jelly, both
alginate and cola jelly significantly reduced iron uptake into the
cells (by 34%, p=0.009 and 35%, p=0.003 respectively). The
combination of cola jelly and calcium produced a very low ferritin
response, 16.5% (p,0.001) of that observed with ferrous gluconate
alone (Fig. 4). The results show that the alginate bead test meal,
similar to that used in the human study, reduced iron availability.
Practical constraints made it impossible to replicate the compo-
sition of the beads exactly; the calcium and iron content of the
beads used for the human study were 1.96 and 1.04 mg/g whereas
for the cell study they were 1.62 and 1.72 mg/g respectively.
Discussion
The human study results were not consistent with the earlier in
vitro results which showed that alginate enhanced iron uptake in
epithelial cells [12]. Calcium exerted a very powerful negative
effect on iron absorption, which was greater with ferrous gluconate
solution (51% decrease) than with the alginate beads (37%
decrease) due, presumably, to the fact that alginate had already
reduced iron absorption by 33%. The possible reasons for the
conflicting findings between the earlier cell studies and the human
study might be the higher level of calcium in the beads plus cola
jelly test meal, and also the lower iron content of the beads
following washing to remove iron adhering to the outside of the
beads (the rinsing step was undertaken to make the preparation
more palatable for the volunteers).
Calcium has a strongly inhibitory effect on iron absorption in
vivo [23] and in vitro [24]. One proposed explanation for the
enhancing effect of alginate in the previous Caco-2 cell studies was
that it bound calcium in the culture medium, thereby reducing the
inhibitory effect of calcium on iron uptake. In the human study,
the calcium dose selected was 600 mg, because this quantity of
calcium was required to achieve a calcium:iron molar ratio of 11:1
with the minimum dose of iron required to produce a measurable
serum response (21 mg). A dose-dependent inhibitory effect of
calcium on absorption of iron has been reported for molar ratios
Figure 3. Iron absorption (% of dose). Mean values 6 SD. Group A,
n = 13; sub-group B, n = 7* (*with the exception of comparison between
test meal 3 and 4 where n = 5). Group A means without a common
symbol (#, D) are significantly different (p= 0.003). Sub-group B means
without a common letter (a, b, c) are significantly different (p,0.05).
doi:10.1371/journal.pone.0112144.g003
Figure 4. Iron uptake in Caco-2 cells exposed to ferrous
gluconate (FeG) alone or in alginate beads, with or without
cola jelly test meal, or with cola jelly test meal in the presence
of calcium phosphate. Bars represent mean 6SD ferritin concentra-
tion (ng/mg total protein) after treatment with 102.3 mmol/L FeG (n = 6
for all treatments). Bars without a common letter (a, b, c, d) are
significantly different, p,0.005 (a.b.c.d). Ferritin concentration in
cells with no treatment was 7.66SD 1.0.
doi:10.1371/journal.pone.0112144.g004
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ranging from 11:1 (40 mg calcium, 5 mg iron) to 83:1 (300 mg
calcium, 5 mg iron) [25], although more recently a higher
threshold molar ratio of 220:1 (800 mg calcium, 5 mg iron) was
reported [26]. Our study demonstrates an inhibitory effect of
calcium at a molar ratio of 11:1 (Figure 3, iron alone 11.5%, iron
plus calcium 5.6%, p= 0.014, n= 7).
There is one other human study in which the effect of alginate
on iron absorption was measured [13]. Six ileostomy patients were
given a low-fiber diet (providing 1,756 mg calcium/d and 7 mg
iron/d) with or without a daily supplement of 7.5 g sodium
alginate. In 5 of the 6 subjects alginate resulted in a lower apparent
absorption of iron, although the results were not statistically
significant due to high inter-individual variation and insufficient
power. However, as the diets were similar apart from the addition
of sodium alginate, the results suggest an inhibitory effect of
alginate.
Bosscher et al. [27] reported that the availability of iron and
zinc from infant formulas increased with the addition of alginic
acid when investigated using an in vitro dialysis model with a
preliminary intraluminal digestive phase. The nature of the
binding of alginate to iron is unknown. Results from circular
dichroism and zeta potential experiments indicate that the
interaction at pH 3.5 (relevant to gastric conditions) is through a
site-binding model, with an estimated 66 sites per molecule of
sodium alginate [10].
Conclusions
The results of the human study and the Caco-2 cell experiments
demonstrated that alginate beads are not a suitable delivery
vehicle for food iron fortification in diets consumed in industri-
alized countries. The inhibitory effect of alginate beads appears to
be linked to calcium; but as calcium is needed for a stable alginate
gel to be formed low-calcium beads are not a viable alternative.
However, with high phytate diets, it is possible that alginate might
bind iron sufficiently tightly to protect it from binding to phytate
(which prevents it being absorbed), and might therefore deliver a
useful quantity of absorbable iron. This is the proposed action of
iron-EDTA and it would be worth investigating whether alginate
can perform a similar function.
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